Transcriptional activation in vitro by the human immunodeficiency virus type 1 Tat protein: evidence for specific interaction with a coactivator(s).
about
A cofactor, TIP30, specifically enhances HIV-1 Tat-activated transcriptionCA150, a nuclear protein associated with the RNA polymerase II holoenzyme, is involved in Tat-activated human immunodeficiency virus type 1 transcriptionIn vitro interaction of the human immunodeficiency virus type 1 Tat transactivator and the general transcription factor TFIIB with the cellular protein TAPBovine papillomavirus type 1 E2 transcriptional regulators directly bind two cellular transcription factors, TFIID and TFIIBRepression in vitro, by human adenovirus E1A protein domains, of basal or Tat-activated transcription of the human immunodeficiency virus type 1 long terminal repeat.Cooperation between herpes simplex virus type 1-encoded ICP0 and Tat to support transcription of human immunodeficiency virus type 1 long terminal repeat in vivo can occur in the absence of the TAR binding site.The adenovirus E1A repression domain disrupts the interaction between the TATA binding protein and the TATA box in a manner reversible by TFIIB.Preventive effect of ascorbic acid against biological function of human immunodeficiency virus trans-activator of transcriptionTranscriptional repression by human adenovirus E1A N terminus/conserved domain 1 polypeptides in vivo and in vitro in the absence of protein synthesis.The human immunodeficiency virus-1 Tat protein activates human umbilical vein endothelial cell E-selectin expression via an NF-kappa B-dependent mechanism.Double hairpin complexes allow accommodation of all four base pairs in triple helices containing both DNA and RNA strands.Sp1 transcription factor is required for in vitro basal and Tat-activated transcription from the human immunodeficiency virus type 1 long terminal repeat.Smad4/DPC4 and Smad3 mediate transforming growth factor-beta (TGF-beta) signaling through direct binding to a novel TGF-beta-responsive element in the human plasminogen activator inhibitor-1 promoter.
P2860
Q24314052-70AA1019-8DF3-4FBA-A95C-CF68B45894D0Q24315725-F8ECBBA0-A760-4770-8405-7FAB6CD43817Q24675459-E2C79733-7ED5-4038-AC24-2DCC15872716Q33292465-AA5EFFF3-FA2B-43E4-B048-44AB64201E1FQ35838772-A14D428D-7E31-4A91-9243-26323AD09F35Q35870516-A05A298C-6258-4711-906A-413FE967A754Q36567742-888AB259-CD79-48CB-892A-743CBC0F51F1Q36810917-C3DC4BF0-67CA-4871-BCB3-AD72395BCB40Q38290628-F29FE6F2-D48F-4756-8DCD-5A0C53180920Q38292349-1E2485FD-0A66-4430-8163-404D6E83A997Q38352876-25D5CD88-910F-4BBD-AC4D-59FCD7629C58Q39872155-266C6BFD-BE44-48A7-8DA2-72278375968DQ40999235-A7D23829-8EBA-4372-8E34-BE760901F883
P2860
Transcriptional activation in vitro by the human immunodeficiency virus type 1 Tat protein: evidence for specific interaction with a coactivator(s).
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Transcriptional activation in ...... raction with a coactivator(s).
@ast
Transcriptional activation in ...... raction with a coactivator(s).
@en
type
label
Transcriptional activation in ...... raction with a coactivator(s).
@ast
Transcriptional activation in ...... raction with a coactivator(s).
@en
prefLabel
Transcriptional activation in ...... raction with a coactivator(s).
@ast
Transcriptional activation in ...... raction with a coactivator(s).
@en
P2093
P2860
P356
P1476
Transcriptional activation in ...... raction with a coactivator(s).
@en
P2093
P2860
P304
P356
10.1073/PNAS.91.20.9357
P407
P577
1994-09-01T00:00:00Z